Dr. Gulati is Professor and Associate Dean at the Midwestern University, Illinois. Dr. Gulati is recipient of 2014 Paul R Dawson Biotechnology Award and Littlejohn Award in 2014. He is a United States Fulbright Scholar 2008-2009 and winner of International Ranbaxy Research Award 2007. He has 305 peer reviewed publications and guided researches of more than 95 graduate students, medical residents and research fellows. He has 43 issued patents. He Co-Chaired ET-14: World Endothelin Conference 2015.
Formerly, Union Health Secretary, Government of India. Mr. Verma is a very senior administrator with deep experience in the health sector. He was instrumental in formulating and implementing many policies related to the drug development process in India. He also has remarkable interest in literary work.
Mr. Gulati has more than 35 years of experience in running operations of various companies. He has considerable experience and knowledge in launching companies, getting required regulatory approvals and making the companies fully operational . Along with that, he also has extensive experience in international trade.
Mr. Srimal is a veteran Global Pharmaceutical Business Manager with a demonstrated international track record of product and market development. As top level Executive Officer he had been instrumental in driving revenues and profits.
Dr. Lavhale did his PhD. in Pharmaceutical Sciences and worked as Research associate at Midwestern University, USA for about 3 years before joining Pharmazz. He has 11 years of research experience. He has been involved in preclinical and clinical development of pharmaceuticals.
Marc Scheetz Advisor attained a Doctorate of Pharmacy from Butler University, earned a Masters of Science in Clinical Investigation from Northwestern University, and completed his residency and fellowship at Northwestern Memorial Hospital. Dr. Scheetz is an Associate Professor at Midwestern University Chicago College of Pharmacy and is the Director for the Post-Doctoral Fellowship Program. He has been involved in various national leadership positions and is an international expert in pharmacometrics.
Mr. Toft graduated with a classical diploma from Phillips Exeter Academy, an A.B. degree with high honors in economics from Dartmouth College, and an MBA in accounting and finance from the Amos Tuck School of Business Administration. Mr. Toft was a founding Principal of Julian, Toft, & Downey, Inc., prior to its merger with Transwestern Commercial Real Estate Services, Inc., where he was a Managing Director. He has been personally responsible for closing more than $3.0 billion in debt and equity financing.
Dr. Andurkar is Professor and Chair of Pharmaceutical Sciences at the Midwestern University Chicago College of Pharmacy. He has pursued a program of research involving the design, synthesis, biological evaluation and metabolism of bioactive molecules for the past 17 years. He has been awarded various Distinctions & Honors like Golden Apple Award, Teacher of the Year, Midwestern University Chicago College of Pharmacy, for many consecutive years. He has to his honor one issued patent.
Dr. Srimal has more than 50 years of leadership, teaching and research experience in Pharmaceutical Institutions. He has been the Director of Indian Institute of Toxicology Research, Lucknow. He is member of National Academy of Medical Sciences and has been a Commonwealth Medical Fellow. He has been consultant to UNIDO, Commonwealth Secretariat and The University of Illinois at Chicago, Chicago, USA.